The combination of CCN5, vWF, GFAP, and OCGB provides a significant increase in PPV; the model is able to accurately discriminate between OCGB+ve CDMS and OCGB+ve non-MS neurological conditions. This evidence concerns the gene CCN5 and myeloid sarcoma.